Loading page…
SillaJen Inc Sustainability Reports
SillaJen, Inc. is a biopharmaceutical company engaged in the research and development of oncolytic virus therapies. The company focuses on clinical-stage immunotherapies for various cancer treatments, including its lead candidate asset Pexa-Vec.
Sector: Professional & technical services
Country: South Korea
Exchange: Korea Exchange (KOSDAQ)
FIGI: BBG005MYVR96
1 reports from 2023 to 2023